These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19903264)

  • 41. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination.
    Baatarjav T; Kataoka K; Gilbert RS; Terao Y; Fukui M; Goto M; Kawabata S; Yamamoto M; Fujihashi K; Ito HO
    Vaccine; 2011 Aug; 29(34):5747-57. PubMed ID: 21683111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced antigen-specific delayed-type hypersensitivity and immunoglobulin G2b responses after oral administration of viable Lactobacillus casei YIT9029 in Wistar and Brown Norway rats.
    de Waard R; Garssen J; Snel J; Bokken GC; Sako T; Veld JH; Vos JG
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):762-7. PubMed ID: 11427423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota.
    Yasui H; Kiyoshima J; Hori T
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):675-9. PubMed ID: 15242940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probiotics induce resistance to enteropathogens in a re-nourished mouse model.
    Cano PG; Perdigón G
    J Dairy Res; 2003 Nov; 70(4):433-40. PubMed ID: 14649414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response.
    Thakur BK; Saha P; Banik G; Saha DR; Grover S; Batish VK; Das S
    Int Immunopharmacol; 2016 Jul; 36():39-50. PubMed ID: 27107798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.
    Arulanandam BP; Lynch JM; Briles DE; Hollingshead S; Metzger DW
    Infect Immun; 2001 Nov; 69(11):6718-24. PubMed ID: 11598043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of the route of administration on immunomodulatory properties of bovine beta-lactoglobulin-producing Lactobacillus casei.
    Hazebrouck S; Przybylski-Nicaise L; Ah-Leung S; Adel-Patient K; Corthier G; Langella P; Wal JM
    Vaccine; 2009 Sep; 27(42):5800-5. PubMed ID: 19654068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced susceptibility to Trichuris muris infection of B10Br mice treated with the probiotic Lactobacillus casei.
    Dea-Ayuela MA; Rama-Iñiguez S; Bolás-Fernandez F
    Int Immunopharmacol; 2008 Jan; 8(1):28-35. PubMed ID: 18068097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary supplementation with Lactobacilli improves emergency granulopoiesis in protein-malnourished mice and enhances respiratory innate immune response.
    Herrera M; Salva S; Villena J; Barbieri N; Marranzino G; Alvarez S
    PLoS One; 2014; 9(4):e90227. PubMed ID: 24691464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage.
    Zelaya H; Tada A; Vizoso-Pinto MG; Salva S; Kanmani P; Agüero G; Alvarez S; Kitazawa H; Villena J
    Inflamm Res; 2015 Aug; 64(8):589-602. PubMed ID: 26072063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice.
    Vintiñi E; Villena J; Alvarez S; Medina M
    Clin Exp Immunol; 2010 Mar; 159(3):351-62. PubMed ID: 20002449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant Lactobacillus casei expressing Clostridium perfringens toxoids α, β2, ε and β1 gives protection against Clostridium perfringens in rabbits.
    Zhao L; Guo Z; Liu J; Wang Z; Wang R; Li Y; Wang L; Xu Y; Tang L; Qiao X
    Vaccine; 2017 Jul; 35(32):4010-4021. PubMed ID: 28625525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.
    Ogawa M; Shimizu K; Nomoto K; Takahashi M; Watanuki M; Tanaka R; Tanaka T; Hamabata T; Yamasaki S; Takeda Y
    Infect Immun; 2001 Feb; 69(2):1101-8. PubMed ID: 11160007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity.
    Galdeano CM; Perdigón G
    Clin Vaccine Immunol; 2006 Feb; 13(2):219-26. PubMed ID: 16467329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
    Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
    Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can Lacticaseibacillus rhamnosus CRL1505 postbiotic improve emergency myelopoiesis in immunocompromised mice?
    López AG; Vasile B; Kolling Y; Ivir M; Gutiérrez F; Alvarez S; Salva S
    Microbes Infect; 2024; 26(4):105311. PubMed ID: 38342337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alterations in Faecal Microbiota and Elevated Levels of Intestinal IgA Following Oral Administration of Lacticaseibacillus casei in mice.
    Aindelis G; Ypsilantis P; Chlichlia K
    Probiotics Antimicrob Proteins; 2023 Jun; 15(3):524-534. PubMed ID: 34676502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of recombinant lactobacillus expressing canine GM-CSF on immune function in dogs.
    Chung JY; Sung EJ; Cho CG; Seo KW; Lee JS; Bhang DH; Lee HW; Hwang CY; Lee WK; Youn HY; Kim CJ
    J Microbiol Biotechnol; 2009 Nov; 19(11):1401-7. PubMed ID: 19996694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.